The findings revealed substantially reduced mRNA levels of m6A, METTL3, METTL14, and YTH N6‐methyladenosine RNA binding protein F2 (YTHDF2) in PD patients compared to controls, with METTL14 identified as the primary cause. Here, METTL3 is linked to Parkinson disease.